Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hirohashi, Y.
103  Ergebnisse:
Personensuche X
?
1

34P Cocktail peptide vaccines targeting cancer stem cells f..:

Miyamoto, S. ; Hirohashi, Y. ; Torigoe, T..
ESMO Open.  9 (2024)  - p. 102362 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Influence of PD-L1 Expression in Immune Cells on the Respon..:

Fukushima, Y. ; Someya, M. ; Nakata, K....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e254 , 2018
Link: https://doi.org/10.1016/..
 
?
3

520 Expression of hepatocyte growth factor in prostate canc..:

Nishida, S. ; Hirohashi, Y. ; Torigoe, T....
European Urology Supplements.  14 (2015)  2 - p. e520-e520a , 2015
Link: https://doi.org/10.1016/..
 
?
4

247 Neuregulin 1 HRG-beta1 plays a critical role in cell su..:

Inoue, R. ; Hirohashi, Y. ; Torigoe, T....
European Urology Supplements.  13 (2014)  1 - p. e247 , 2014
Link: https://doi.org/10.1016/..
 
?
5

Preferential expression of cancer/testis genes in cancer st..:

Yamada, R. ; Takahashi, A. ; Torigoe, T....
Tissue Antigens.  81 (2013)  6 - p. 428-434 , 2013
Link: https://doi.org/10.1111/..
 
?
6

P032 Preclinical study of a novel immunotherapy for renal c..:

Kitamura, H. ; Torigoe, T. ; Hirohashi, Y....
European Urology Supplements.  12 (2013)  6 - p. 141 , 2013
Link: https://doi.org/10.1016/..
 
?
7

767 Identification of antigenic peptides from novel renal c..:

Satoshi, N. ; Hirohashi, Y. ; Torigoe, T....
European Urology Supplements.  12 (2013)  1 - p. e767-e768 , 2013
Link: https://doi.org/10.1016/..
 
?
8

199 PHD3 expression is a predictor of progression-free surv..:

Tanaka, T. ; Kitamura, H. ; Torigoe, T....
European Urology Supplements.  11 (2012)  1 - p. e199-e199a , 2012
Link: https://doi.org/10.1016/..
 
?
9

M278 Withdrawn M279 NOVEL OLIGOMANNOSE LIPOSOME‐DNA COMPLEX..:

Saito, T. ; Mizuuchi, M. ; Hirohashi, Y...
International Journal of Gynecology & Obstetrics.  119 (2012)  S3 - p. , 2012
Link: https://doi.org/10.1016/..
 
?
10

663 Phase I clinical study of survivin-derived peptide vacc..:

Tanaka, T. ; Kitamura, H. ; Torigoe, T....
European Urology Supplements.  11 (2012)  1 - p. e663-e663a , 2012
Link: https://doi.org/10.1016/..
 
?
11

839 GENE EXPRESSION PROFILING OF PROSTATE CANCER STEM CELLS..:

Nishida, S. ; Torigoe, T. ; Hirohashi, Y....
European Urology Supplements.  10 (2011)  2 - p. 265-266 , 2011
Link: https://doi.org/10.1016/..
 
?
12

7107 POSTER DISCUSSION Prognostic Impact of the Expression ..:

Kitamura, H. ; Torigoe, T. ; Hirohashi, Y....
European Journal of Cancer.  47 (2011)  - p. S506 , 2011
Link: https://doi.org/10.1016/..
 
?
13

676 PHD3 is expressed independently of HIF protein and has ..:

Tanaka, T. ; Torigoe, T. ; Hirohashi, Y....
European Journal of Cancer Supplements.  8 (2010)  5 - p. 170-171 , 2010
Link: https://doi.org/10.1016/..
 
?
14

ABERRANT EXPRESSION AND POTENCY AS A CANCER IMMUNOTHERAPY T..:

Honma, I. ; Torigoe, T. ; Hirohashi, Y....
European Urology Supplements.  5 (2006)  2 - p. 162 , 2006
Link: https://doi.org/10.1016/..
 
?
15

Emerging concepts in biomarker discovery; the US-Japan Work..:

Tahara H ; Sato M ; Thurin M...
info:eu-repo/semantics/altIdentifier/pmid/19534815.  , 2009
Link: http://hdl.handle.net/11..
 
1-15